This aging mechanism is closely related to various common diseases, including atherosclerosis, hypertension, chronic obstructive pulmonary disease, diabetes, and neurodegenerative disorders ( Current senolytic agents are primarily employed in cancer therapies, such as doxorubicin, trametinib, and cell cycle-targeting drugs like palbociclib ( Although studies have shown that FOXO4-DRI can block the binding of P53 to FOXO4, thereby promoting the apoptosis of senescent cells, the effect of FOXO4-DRI is not limited to alleviating the aging of certain organs
You need a valid prescription from a qualified healthcare professional
And does it work better for weight loss than Ozempic and Wegovy
Boosts Energy & Stamina: Supports red blood cell production and oxygen transport to fight fatigue and improve endurance
Why Personalized Peptide Care Matters Peptide therapy at Endocrinology Associates isnt one-size-fits-all